Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging

AAK Abdel Razek, A Alksas, M Shehata… - Insights into …, 2021 - Springer
This article is a comprehensive review of the basic background, technique, and clinical
applications of artificial intelligence (AI) and radiomics in the field of neuro-oncology. A …

Emerging applications of artificial intelligence in neuro-oncology

JD Rudie, AM Rauschecker, RN Bryan, C Davatzikos… - Radiology, 2019 - pubs.rsna.org
Due to the exponential growth of computational algorithms, artificial intelligence (AI)
methods are poised to improve the precision of diagnostic and therapeutic methods in …

Robust radiomics feature quantification using semiautomatic volumetric segmentation

C Parmar, E Rios Velazquez, R Leijenaar… - PloS one, 2014 - journals.plos.org
Due to advances in the acquisition and analysis of medical imaging, it is currently possible
to quantify the tumor phenotype. The emerging field of Radiomics addresses this issue by …

Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features

O Gevaert, LA Mitchell, AS Achrol, J Xu, S Echegaray… - Radiology, 2014 - pubs.rsna.org
Purpose To derive quantitative image features from magnetic resonance (MR) images that
characterize the radiographic phenotype of glioblastoma multiforme (GBM) lesions and to …

Combining molecular and imaging metrics in cancer: radiogenomics

R Lo Gullo, I Daimiel, EA Morris, K Pinker - Insights into imaging, 2020 - Springer
Background Radiogenomics is the extension of radiomics through the combination of
genetic and radiomic data. Because genetic testing remains expensive, invasive, and time …

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma

N Elshafeey, A Kotrotsou, A Hassan, N Elshafei… - Nature …, 2019 - nature.com
Pseudoprogression (PsP) is a diagnostic clinical dilemma in cancer. In this study, we
retrospectively analyse glioblastoma patients, and using their dynamic susceptibility contrast …

Imaging signatures of glioblastoma molecular characteristics: a radiogenomics review

A Fathi Kazerooni, S Bakas… - Journal of Magnetic …, 2020 - Wiley Online Library
Over the past few decades, the advent and development of genomic assessment methods
and computational approaches have raised the hopes for identifying therapeutic targets that …

Radiogenomic analysis of oncological data: a technical survey

M Incoronato, M Aiello, T Infante, C Cavaliere… - International journal of …, 2017 - mdpi.com
In the last few years, biomedical research has been boosted by the technological
development of analytical instrumentation generating a large volume of data. Such …

Treatment response assessment in IDH-mutant glioma patients by noninvasive 3D functional spectroscopic mapping of 2-hydroxyglutarate

OC Andronesi, F Loebel, W Bogner, M Marjańska… - Clinical cancer …, 2016 - AACR
Purpose: Measurements of objective response rates are critical to evaluate new glioma
therapies. The hallmark metabolic alteration in gliomas with mutant isocitrate …

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

S Qiu, S Lin, D Hu, Y Feng, Y Tan, Y Peng - Journal of translational …, 2013 - Springer
Background Glioblastoma multiforme (GBM) is the most common and aggressive brain
tumor with poor clinical outcome. Identification and development of new markers could be …